Stefan EG Burdach

from Wikipedia, the free encyclopedia

Stefan EG Burdach (* 1952 in Berlin ) is a German pediatrician , oncologist , cancer researcher and university professor . His scientific focus is on malignant sarcomas in children and adolescents, cell and gene therapy .

Career

Burdach received his doctorate in 1980 from the University of Cologne . His specialist training took place from 1978 to 1983 at the children's hospital in Cologne. He then spent research stays at Harvard University , Stanford University and with Edward Donnall Thomas at the Fred Hutchinson Cancer Research Center in Seattle , where he trained in stem cell transplantation . In 1989 he completed his habilitation in Düsseldorf . In 1997 he was appointed to a professorship for general pediatrics at the Martin Luther University in Halle-Wittenberg .

In 2003 he became a professor at the Chair of Pediatric and Adolescent Medicine at the Technical University of Munich . He is Director of the Clinic and Polyclinic for Pediatric and Adolescent Medicine at the Klinikum rechts der Isar and chief physician at the Children's Clinic in Munich Schwabing . In July 2020 he was also appointed Affiliate Scientist at the British Columbia Cancer Research Institute .

Burdach is the author of over 500 publications with over 7,000 citations (Web of Science). He also acts as a reviewer for the German Research Foundation , the Helmholtz Association , the Wilhelm Sander Foundation , the German Cancer Aid , the German Children's Cancer Foundation and the German José Carreras Leukemia Foundation .

Awards (selection)

  • 1987: Hill Memorial Award , Stanford University
  • 1991: Reinhard Heynen and Emmi Heynen Prize, Heinrich Heine University Düsseldorf
  • 2009: Kind Philipp Prize of the Society for Pediatric Oncology and Hematology in the Stifterverband for German science for work on stem cells and cancer mechanisms.

Publications (selection)

  • with U. von Freeden-Jeffry, P. Vieira, LA Lucian, T. McNeil, R., Murray: Lymphopenia in interleukin (IL) -7 gene-deleted mice identifies IL-7 as a nonredundant cytokine . In: Journal of Experimental Medicine. 1995; 181 (4): 1519-1526.
  • with F. Berthold, J. Boos et al .: Myeloablative megatherapy with autologous stem-cell rescue versus oral maintenance chemotherapy as consolidation treatment in patients with high-risk neuroblastoma: a randomized controlled trial. LANCET ONCOLOGY Volume: 6 Issue: 9 Pages: 649-658 Published: SEP 2005
  • with HJ Kolb: The vigor of defense against non-self: potential superiority of allorestricted T cells in immunotherapy of cancer? . Front oncol. 2013; 3: 100. Published 2013 May 3. doi: 10.3389 / fonc.2013.00100

Web links

Individual evidence

  1. a b c d Prof. Dr. med. Burdach: pediatrician, oncologist, cancer specialist and pediatrician. Retrieved July 19, 2020 .
  2. a b c d e f g Prof. Dr. Stefan Burdach. In: Technical University of Munich. Retrieved July 19, 2020 .